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ABSTRACT 
 The use of attention training protocols for the treatment of generalized social anxiety 
disorder (SAD) is undergoing increased examination. Initial investigations were positive but 
more recent investigations have been less supportive of the treatment paradigm. One significant 
limitation of current investigations may be over-reliance on self-report. In this investigation, we 
expanded on initial investigations by using a multimodal assessment of patient functioning (i.e., 
including behavioral assessment). Patients with a primary diagnosis of SAD (n = 31) were 
randomly assigned to eight sessions of attention training (n = 15) or placebo/control (n = 16). 
Participants were assessed at pre- and post-treatment via self- and clinician-report of social 
anxiety as well as anxious and behavioral response to two in vivo social interactions. Results 
revealed no differences between groups at post-treatment for all study outcome variables, 
suggesting a lack of effect for the attention training condition. The results are concordant with 
recent investigations finding a lack of support for the use of attention training as an efficacious 
treatment for patients with SAD. 
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INTRODUCTION 
Individuals presenting with social anxiety disorder (SAD; also termed social phobia) 
experience an intense fear and apprehension of social situations during which they might be 
evaluated by others (DSM-IV-TR; American Psychiatric Association [APA], 2000). In addition 
to the distress associated with these social situations, SAD is frequently marked by avoidance of 
the anxiety-provoking situation (e.g., avoiding conversations and/or giving presentations in a 
class or at work). The physiological and psychological distress, anticipatory response, and 
behavioral avoidance associated with SAD create significant functional impairment. Two 
subtypes have been identified for people with SAD. These include the nongeneralized or specific 
(social fears are limited to few, specific social situations) and the generalized (social fears are 
present in most social situations) subtypes (APA, 2000). 
SAD is a common disorder, with prevalence rates ranging from 1-15% of the general 
population (APA, 2000; Costello, Eggar, & Angold, 2004; Costello, Eggar, & Angold, 2005; 
Heimberg, Stein, Hiripi, & Kessler, 2000) and the typical age of onset is early to mid-
adolescence (age 11 to 15; DeWit, Ogborne, Offord & MacDonald, 1999; Silverman et al., 1999; 
Weiss & Last, 2001). Earlier onset SAD is associated with more negative outcomes including co-
morbid anxiety disorders, depression, substance use, and conduct problems later in life (Beidel & 
Turner, 1998; Grant et al., 2005; Kessler, 2003; Lecrubier, 1998).  
Of particular importance, relative to impairment, is that an early history of SAD may also 
result in dysfunctional social skills (Beidel, Rao, Scharfstein, Wong, & Alfano, 2010; Turner, 
Beidel, Dancu, & Stanley, 1989). As children and adolescents with SAD progressively avoid 
social situations, they miss opportunities to develop the social skills necessary for effective social 
interaction. The pattern of inadequate skill and social distress associated with SAD, in turn, may 
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result in additional negative effects (e.g., co-morbid anxiety disorders, depression, substance 
abuse, and behavioral problems), and create significantly more dysfunction (e.g., dropping out of 
school, turning down job offers, interpersonal relationship problems) with age (Clark, 1993; 
Costello et al., 2003; Lecrubier, 1998; Rao et al., 2007; Stein, Torgrud, & Walker, 2000). 
In addition to its behavioral elements, cognitive aspects of SAD have received increased 
attention. According to cognitive theories, anxious individuals direct their attention toward 
threatening stimuli pertinent to their specific concerns (e.g., Beck, Emery, & Greenberg, 1985; 
Eysenck, 1997; Mogg & Bradley, 1998; Rapee & Heimberg, 1997; Williams, Watts, MacLeod, 
& Mathews, 1997). This attentional bias is theorized to be influential in the etiological and 
maintenance aspects of anxiety disorders, particularly SAD, and has therefore translated into 
research examining attentional biases toward symptom-specific stimuli associated with SAD. 
There has been increasing interest in the role of attentional bias theory in SAD (e.g., 
Asmundson & Stein, 1994; Becker, Rinck, Margraf, & Roth, 2001; Bradley, Mogg, & Millar, 
1999). Yet some research suggests that socially anxious individuals ultimately avoid, rather than 
selectively attend to, external socially threatening stimuli (Chen, Ehlers, Clark & Mansell, 2002; 
Clark & Wells, 1995; Gamble & Rapee, 2010; Garner, Mogg, & Bradley, 2006; Mansell, Clark, 
Ehlers, & Chen, 1999). Furthermore, other studies suggest there is little or no relationship and 
results have varied depending on contextual factors (Bradley et al., 1997; Mansell, Ehlers, Clark, 
& Chen, 2002; Pineles & Mineka, 2005). 
 Support for the existence of attentional biases in socially anxious participants has been 
found using a variety of measurement methods. Examples of these include heightened activation 
of the anterior cingulate cortex while viewing socially evaluative faces (Amir et al., 2005), 
elevated duration of eye-gaze toward faces with emotional valence as measured by infrared eye 
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tracking systems (Bradley, Mogg, & Millar, 1999), and biased responding toward socially 
threatening/related words during modified Stroop (1935) Color-Naming Tasks (Becker, Rinck, 
Margraf, & Roth, 2001; Holle, Neely, & Heimberg, 1997; Hope, Rapee, Heimberg, & Dombeck, 
1990; Maidenberg, Chen, Craske, Bohn, & Bystritsky, 1996; Mattia, Heimberg, & Hope, 1993; 
McNeil et al., 1995; Spector, Pecknold, & Libman, 2003). Computerized dot-probe paradigms 
(MacLeod, Mathews, & Tata, 1986) have also been used to measure attentional biases in this 
population. Briefly, this paradigm includes the short presentation (typically 500ms) of two 
stimuli (e.g., neutral/threatening words or pictures). Upon the disappearance of the stimuli, a dot 
(also referred to as a probe) appears in the place of one of the stimuli. Conceptually, a participant 
is biased toward attending to a particular stimulus type (e.g., a picture of a socially-threatening 
face) if he or she recognizes the presence of the dot with increased speed and accuracy when it 
takes the place of that particular stimulus type. Based on the use of this paradigm, attentional 
biases in socially anxious samples have been observed toward socially-threatening words (Amir, 
Elias, Klumpp, & Przeworski, 2003; Asmundson & Stein, 1994; Ononaiye, Turpin, & Reidy, 
2007) and later pictures of socially-threatening faces (Mogg & Bradley, 2002; Mogg, Philippot, 
& Bradley, 2004; Pishyar, Harris, & Menzies, 2004; Sposari & Rapee, 2007), as single words are 
unlikely to be the source of threat while participants with SAD engage in social situations 
(Bradley et al., 1997).  
Researchers also have examined the manipulability of attentional biases. For example, 
some investigations have observed decreases in the severity of attentional biases following 
cognitive behavioral therapy (Calamaras, Tone, & Anderson, 2012; Mattia et al., 1993; Pishyar, 
Harris, & Menzies, 2008; Price, Tone, & Anderson, 2011). The potential malleability of 
attentional biases prompted the designing of specific attention training paradigms for participants 
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with social anxiety. Studies examining the utility of attention training (also attention bias 
modification) treatments in people with SAD are emerging. Two initial randomized control trials 
(RCTs) used an identical eight-session attention training protocol (i.e., Amir et al., 2009 and 
Schmidt, Richey, Buckner, & Timpano, 2009), and both concluded that treatment gains were 
observed in the treatment condition above and beyond that of a placebo control. However, in one 
trial, significant between-group differences were not observed at post-treatment for clinician- and 
self-report measures (Schmidt et al., 2009). 
Infrequently discussed, but nonetheless important caveats also exist regarding the extent 
of clinically significant change observed in these investigations. Specifically, although statistical 
differences in self- and clinician-reported social anxiety were observed between the treatment 
conditions, at post-treatment average scores on these measures still fell far above the scores 
delineating the clinical range for SAD, as recommended by prior literature. For example, average 
post-treatment scores on the Social Phobia and Anxiety Inventory (SPAI; Turner, Beidel, & 
Dancu, 1996) were 99.1 (Amir et al., 2009) and 92.47 (Schmidt et al., 2009), exceeding 
established cut-off scores of 60 for probable SAD. Despite self-reported social anxiety, large 
percentages of treated participants no longer met diagnostic criteria for SAD (50% and 72% for 
Amir et al. (2009) and Schmidt et al. (2009), respectively). Moreover, neither investigation 
attempted to examine changes in participants’ social behavior during social interactions, 
previously identified as a common deficit in patients with SAD and a considerable feature of the 
disorder (Beidel et al., 2010; Turner et al., 1989). Since the time of the initial publication, 
subsequent RCTs have failed to replicate the initial positive outcome (Boettcher, Berger, & 
Renneberg, 2011; Carlbring et al., 2012; Heeren, Reese, McNally, & Philippot, 2012; Neubauer 
et al., 2012) whether delivered in person or over the internet.  
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To date, no study has replicated carefully the methodology of the initial investigations 
(Amir et al., 2009; Schmidt et al., 2009) while conducting a multimodal assessment of patient 
functioning (e.g., including behavioral assessment of patient functioning in addition to reports of 
social anxiety). Expanding the assessment strategy will allow examination of changes in social 
behavior and provide further elucidation of the clinically significant utility of this treatment. The 
specific hypotheses are as follows: 1) at post-treatment the percent of participants meeting 
diagnostic criteria for SAD in the treatment condition will be significantly lower than the percent 
meeting criteria in the placebo condition, 2) at post-treatment the mean SPAI score for the 
treatment condition will be significantly lower than that of the control condition, and 3) at post-
treatment participants in the treatment condition will show significant improvement in social 
behavior during in-vivo social interactions, as reflected by increases in duration of eye-contact 
and time speaking as well as decreases in self-reported anxiety, relative to the control condition. 
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METHOD 
Procedure 
Following informed consent, participants were assessed via a clinician administered 
diagnostic interview, self- and clinician-report measures, and a behavioral assessment of social 
skills at our Anxiety Disorders Clinic in the Southeastern United States. As in previous 
investigations, participants were informed that they would be randomly assigned to one of two 
groups: one group would receive the anxiety treatment and the other group would participate in 
the non-treatment condition. Participants were informed that the purpose of the study would be 
to evaluate the usefulness of new computer-based treatments for anxiety. They were then 
randomly assigned to either the Attention Training (AT; n = 15) or Attention Control (AC; n = 
16) condition using a Microsoft Excel random number generator formula. Participants completed 
a total of eight, bi-weekly treatment sessions during which they were instructed to attempt to 
identify the letter probe (E or F) as rapidly as possible without sacrificing accuracy. Following 
the completion of eight sessions, participants completed the post-treatment assessment, which 
was identical to the pre-treatment assessment. All assessments and treatment sessions were 
administered by senior doctoral students in clinical psychology (the first and third authors). Both 
the clinicians and participants were blinded to treatment condition until the conclusion of the 
study. 
Participants 
 Participants were recruited via community advertisements targeting “shy adults”. 
Participants completed a telephone screen, followed by an in-person diagnostic interview, self- 
and clinician-report measures, and a behavioral assessment. Participants who met DSM-IV-TR 
criteria for a primary diagnosis of generalized SAD were invited to participate in the study. 
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Exclusionary criteria (from Amir et al., 2009 and Schmidt et al., 2009) included (a) evidence of 
severe depression or suicidal intent, (b) evidence of current substance abuse or dependence, (c) 
evidence of current or past schizophrenia, bipolar disorder, or organic mental disorder, (d) any 
concurrent psychotherapy, (e) change in pharmacological treatments during the 12 weeks prior to 
study entry, and (f) cognitive–behavioral therapy within the previous 6 months.  
 A total of 31 adults participated in the study. Participants in the AT condition ranged 
from 18 to 45 years of age (M = 24.20, SD = 7.99) and those in the AC condition ranged from 18 
to 44 years of age (M = 24.44, SD = 6.96). The two groups did not differ significantly in age, 
F(1,29) = .008, p = .930, ηp2 = .000. There were slightly more males (62.5%) than females 
(37.5%) in the AC condition, whereas the opposite was true in the AT condition (46.7% and 
53.3%, respectively) but the difference was not statistically significant, χ2(1, 31) = .784, p = .376, 
Φ = .159. Similarly, there were no group differences in race/ethnicity, χ2(4, 31) = 2.372, p = .668, 
Φ = .277. The AT condition was comprised mostly of Caucasians (53.3%), but also included 
Hispanic/Latino (26.7%), Asian/Asian Indian (13.3%), and African American (6.7%) 
participants. Caucasians (56.2%) made up the majority of the AC condition, which also included 
Asian/Asian Indian (18.8%), Hispanic/Latino (18.8%), and Biracial (6.3%) participants. There 
were co-morbid diagnoses within both conditions. Specifically, 33.3% of the AT condition and 
18.8% of the AC condition met criteria for a secondary diagnosis, although this difference was 
not statistically significant, χ2(6, 31) = 8.368, p = .212, Φ = .520. Co-morbid diagnoses in the AT 
condition included major depressive disorder (in partial remission; 6.7%), dysthymic disorder 
(6.7%), panic disorder without agoraphobia (6.7%), and specific phobia (13.3%). Co-morbid 
diagnoses in the AC condition included major depressive disorder (in either partial or full 
remission; 18.8%). See Table 1 for participant demographics. 
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Table 1 
Demographics 
  AT (n = 15) 
 AC 
(n = 16) 
  M (SD)  M (SD) 
Age  24.20 (7.99)  24.44 (6.96) 
     
  n (%)  n (%) 
Sex     
     Male  7 (46.7)  10 (62.5) 
      Female  8 (53.36)  6 (37.5) 
Race     
     African American  1 (6.7)  0 (0.0) 
     Asian/Asian Indian  2 (13.3)  3 (18.8) 
     Caucasian  8 (53.3)  9 (56.2) 
     Latino/a  4 (26.7)  3 (18.8) 
     Biracial  0 (0.0)  1 (6.2) 
Comorbid Diagnoses     
     Major Depressive Disorder  1 (6.7)  3 (18.8) 
     Dysthymia  1 (6.7)  0 (0.0) 
     Specific Phobia  2 (13.3)  0 (0.0) 
     Panic Disorder without Agoraphobia  1 (6.7)  0 (0.0) 
Note. All patients with major depressive disorder were in either partial or full remission. 
Assessment 
Diagnosis and Severity  
Diagnostic interview. The Anxiety Disorders Interview Schedule (ADIS; Brown, 
Dinardo, & Barlow, 1994) was used to assess for DSM-IV-TR Axis-I diagnoses. The ADIS was 
administered by trained doctoral student clinicians who demonstrated both aptitude and interrater 
reliability in performance prior to the start of the study. Training to proficiency followed similar 
methods used by Schmidt and colleagues (2009; reviewing ADIS training tapes, observing taped 
ADIS administration, observing live ADIS administration, and conducting ADIS interviews with 
a trained interviewer) to facilitate an accurate replication. Diagnoses were determined during 
weekly clinical meetings under the direction of a licensed clinical psychologist (the second 
author). Twenty percent of all diagnostic interviews conducted during the study were audio-
recorded and rated by a blinded clinician to establish inter-rater reliability, which was excellent 
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(κ =1.0). 
Clinician-rated measures. The Clinical Global Impressions (CGI; Guy, 1976) Severity 
of Illness and Improvement Scales are rated on an 8-point Likert-type rating scale (rated 0 to 7; 
not at all ill/very much improved to among the most extremely ill patients/very much worse). The 
CGI-Severity scale reflects the severity of the patient’s condition and the CGI-Improvement 
scale reflects the degree to which the patient improved from pre- to post- treatment, based on the 
perception of the clinician. Participants with scores of either two or one (much improved or very 
much improved respectively) on the CGI-Improvement at post-treatment were classified as 
treatment responders. 
The Behavioral Avoidance Rating Scale (BARS; Beidel et al., 2007) is a 7-point Likert-
type scale (rated 0 to 6; no avoidance to complete avoidance) developed by the second author 
and reflects the degree to which the patient avoids social situations. Twenty percent of all 
clinician-rated measures were rated by a blinded clinician to establish inter-rater reliability, 
which was adequate for the CGI severity (ICC = .91), CGI-Improvement (ICC = 1.00), and 
BARS (ICC = .79). 
Social Anxiety 
Clinician-rated measure. The Brief Social Phobia Scale (BSPS; Davidson et al., 1991) is 
an 11-item clinician-administered measure comprised of seven social situations and four 
physiological symptoms (i.e., blushing, palpitations, trembling, sweating) commonly 
experienced by individuals with SAD. Clinicians rate the patient’s fear and avoidance relative to 
the social situations along with the severity of their physiological symptoms using a 5-point 
Likert-type rating scale (rated 0 to 4; none to extreme). Inter-rater reliability was adequate for the 
BSPS (ICC = .88). 
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Self-report measures. The Social Phobia and Anxiety Inventory (SPAI; Turner et al., 
1989; Turner, Beidel, & Dancu, 1996) is an empirically derived self-report measure that includes 
45 items rated on a 7-point Likert-type scale (rated 0 to 6; never to always) reflecting the 
frequency of the rater’s experiences. The SPAI provides both a Social Phobia and Agoraphobia 
subscale, and a difference score of the two which indicates a more pure measure of SAD, and 
which was used as the primary outcome measure of the current investigation. The SPAI has 
demonstrated good psychometric properties (Beidel, Turner, et al., 1989; Bunnell, Joseph, & 
Beidel, 2012; Turner, Beidel, et al., 1989). The internal consistency was adequate for the SPAI 
(Cronbach’s α = .97) in the current sample. 
The Liebowitz Social Anxiety Scale-Self Report (LSAS-SR; Liebowitz, 1987) is a 24-
item self-report measure that assesses both fear (rated 0 to 3; none to severe) and avoidance 
(rated 0 to 3; never to usually) of social interaction and performance situations. The LSAS-SR 
has demonstrated good psychometric properties (Baker, Heinrichs, Kim, & Hofmann, 2002; 
Fresco et al., 2001) and scores are comparable to those of the clinician-rated version (Fresco et 
al., 2001). The internal consistency was adequate for the LSAS-SR (Cronbach’s α = .89) in the 
current sample. 
Depression 
The Beck Depression Inventory–II (BDI-II; Beck, Steer, & Brown, 1996) is a self-report 
measure of depressive symptoms with 21 items which are rated on Likert-type scale (rated 0 to 
3). The BDI-II has demonstrated good psychometric properties (Dozois, Dobson, & Ahnberg, 
1998). The internal consistency was adequate for the BDI-II (Cronbach’s α = .91) in the current 
sample. 
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Behavioral Assessment of Social Anxiety and Behavior 
A behavioral assessment was used to assess social behaviors and anxiety at pre- and post-
treatment. The two in-vivo social interaction tasks included an adapted Unstructured 
Conversation Task (UCT; Turner, Beidel, Cooley, & Woody, 1994) and an Impromptu Speech 
Task (IST; Beidel et al., 2010). Each participant rated their level of anxiety immediately 
following each task using a 9-point Likert-type rating scale (0 to 8; no distress to extreme 
distress). Behavioral assessments were video and audio recorded and behaviors were coded by 
independent raters (blinded to treatment condition and time of assessment) using the Noldus 
Observer XT (Version 10.1; Noldus Information Technology, 2010). Briefly, the Noldus 
Observer XT software allows for the coding of behaviors at various playback speeds with exact 
precision (in hundredths of seconds). The Observer XT provides an output with the duration and 
frequency of each behavior, which can then be used for statistical analyses and comparisons. 
 UCT. The UCT involved a 5-minute social interaction during which participants were 
given one of two scenarios, which was randomly selected at pre-treatment. The unused scenario 
was given during the post-treatment UCT. The two scenarios were a) moving into a new house 
and meeting a new neighbor and b) meeting someone at a dinner party. Participants were 
instructed to “get to know [the confederate] by having a conversation with him/her”. In these 
unstructured tasks, confederates were trained to respond to the participant in a pleasantly neutral 
manner without leading the conversation, and the sex of the confederate was randomized for 
each assessment. Social behaviors were coded using the Noldus Observer XT as the total 
duration (in seconds) of each participant’s eye/facial gaze and time spent speaking during the 
UCT. Additionally, the participants’ self-reported anxiety during the task was recorded using the 
9-point Likert-type scale described above. 
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 IST. The IST required participants to prepare a 10-minute speech and deliver it to an 
audience of five confederates. Participants were given three minutes to prepare the speech using 
a maximum of three out of five topics provided by the experimenter. Participants were allowed 
to terminate the speech after three minutes by holding up a “stop card”, if the distress from 
speaking became too great. Social behaviors were coded, using the Noldus Observer XT, as the 
total duration (in seconds) of each participant’s time spent speaking, eye/facial gaze, and time 
before requesting to end the task during the IST. Escape behavior (i.e., requesting to end the task 
early) was also coded. Additionally, the participants’ self-reported anxiety during the task was 
recorded using the 9-point Likert-type scale described above. 
Treatment Credibility 
 Three questions regarding treatment credibility (adapted from Borkovec & Nau, 1972) 
were administered following the second treatment session. These measures assessed confidence 
in treatment, perception of logicalness of treatment, and confidence in recommending the 
treatment to a friend. Responses were rated on a 3-point Likert-type scale (0 to 3; not at all to 
very much). 
Treatment 
Materials. Faces used for the treatment program were selected from a standardized set of 
emotional expressions (Matsumoto & Ekman, 1989). The set includes pictures of faces of eight 
individuals (four men and four women) displaying neutral and negative/threatening (i.e., disgust) 
expressions. Pictures were centered horizontally 17.5 cm from the left edge of the screen and 3.0 
cm from the top of the screen, and there was a 1.5 cm gap between the bottom of the top image 
and the top of the bottom image. Pictures were presented against a static light grey background 
via LCD computer monitor. Trials were conducted using E-Prime Professional 2.0 (Psychology 
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Software Tools, Inc., Sharpsburg, PA). An independent research assistant created desktop links 
to each condition that were masked by ambiguous names (e.g., “Skinner” or “Jung”) to blind 
clinicians and participants to treatment condition. These ambiguous names were entered next to 
the participants’ names on a tracking sheet to ensure that their assigned treatment was 
administered. 
Attention Training. The attention training protocol mirrored that conducted by Amir et 
al. (2009) and Schmidt et al. (2009), who used a modified dot-probe paradigm originally 
designed by MacLeod et al. (1986). Each trial began with the presentation of a fixation cross 
(“+”) in the center of the monitor for 500ms. Two faces of the same individual were then 
presented (one on top and one on bottom) for 500ms. Each pair of faces displayed one of two 
combinations of emotions (i.e., neutral and disgust, or neutral and neutral). Following this 
presentation, a probe (the letter E or F) replaced one of the two faces, and participants pressed 
the corresponding button (right or left) on the computer mouse to identify either a probe of E or 
F. A new trial began following the participants’ response. During each session, participants 
observed a total of 160 trials, 128 (80%) of which included the presentation of the probe in place 
of a neutral face: 2 (disgust face position: top or bottom) × 2 (probe type: E or F) × 8 (person) × 
4 (repetition). The remaining 32 (20%) trials included only neutral faces: 2 (probe type: E or F) × 
2 (probe position: top or bottom) × 8 (person).  
Attention Control. The AC condition replicated the AT condition with the exception of 
the frequency in which the probe appeared in the place of neutral expressions rather than those of 
disgust. A total of 160 trials were conducted and included 64 trials (40%; neutral-disgust) where 
the probe replaced the disgust face, 64 trials (40%; neutral-disgust) where the probe replaced the 
neutral face, and 32 trials (20%) where only neutral faces were presented. 
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RESULTS 
Statistical Analyses 
Preliminary analyses indicated that participants in the two treatment conditions did not 
differ significantly on any outcome measure at pre-treatment. Post-treatment data were complete 
for all participants with the exception of behavioral data for one participant in the AT condition 
who completed all treatment sessions and post-treatment assessment measures but refused to 
participate in the behavioral assessment at post-treatment (See Figure 1). The intention-to-treat 
approach was used for this participant when analyzing post-treatment behavioral assessment data. 
Analysis of covariance (ANCOVA) was used to compare post-treatment scores while co-varying 
for pre-treatment scores, as recommended by Van Bruekelen (2006). Chi square and analysis of 
variance (ANOVA) were used to examine differences between groups for variables which were 
categorical (i.e., treatment responder status, escape during the speech task) or had no pre-
treatment scores (i.e., CGI-Improvement scores, treatment credibility). Means, standard 
deviations, and between-group effect sizes for outcome variables are displayed in Table 2. 
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Diagnosis and Severity at Post-Treatment 
 All participants met DSM-IV-TR diagnostic criteria for SAD at post-treatment. Scores on 
the CGI-Improvement scale were not significantly different between the two conditions, F(1,29) 
= .151, p = .701, ηp2 = .005. One participant in the AT condition (6.7%) was classified as a 
treatment responder (i.e., received a score of 1 or 2 on the CGI-Improvement scale) whereas no 
participants in the AC condition were classified as a responder, a difference that was not 
statistically significant, χ2(1, 31) = 1.102, p = .294, Φ = .189. Consistently, participants in the 
Assessed for eligibility (n= 39) 
Excluded (n=6) 
♦   Not meeting inclusion criteria (n=2) 
♦   Declined to participate (n=5) 
Analyzed (n=15) 
♦ Excluded from analysis (n=0) 
Lost to post-treatment (substance use) (n=1) 
Discontinued intervention (n=0) 
Allocated to intervention (n=16) 
♦ Received allocated intervention (n=16) 
♦ Did not receive allocated intervention (n=0) 
Lost to post-treatment (n=0) 
Discontinued intervention (n=0) 
Allocated to control (n=16) 
♦ Received allocated intervention (n=16) 
♦ Did not receive allocated intervention (n=0) 
Analyzed (n=16) 
♦ Excluded from analysis (n=0) 
 
Randomized (n=32) 
Figure 1 
Consort Diagram 
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two treatment conditions did not differ significantly at post-treatment on CGI-Severity scores, 
F(1,28) = .315, p = .579, ηp2 = .011, or BARS ratings, F(1,28) = .127, p = .724, ηp2 = .005. 
Social Anxiety 
Clinician-rated measure. Participants in the two treatment conditions did not differ 
significantly at post-treatment on BSPS scores, F(1,28) = .034, p = .856, ηp2 = .001. 
Self-report measures. Participants in the two treatment conditions did not differ 
significantly at post-treatment on SPAI, F(1,28) = .748, p = .394, ηp2 = .026, or LSAS-SR scores, 
F(1,28) = 2.343, p = .138, ηp2 = .080. 
Depression 
 Participants in the two treatment conditions did not differ significantly at post-treatment 
on BDI-II scores, F(1,28) = .654, p = .426, ηp2 = .023. 
Behavioral Assessment of Anxiety and Social Behavior 
Anxiety level during social interactions. Participants in the two treatment conditions 
did not differ significantly at post-treatment on self-reported anxiety during the UCT, F(1,28) 
= .315, p = .579, ηp2 = .011, or the IST, F(1,28) = .058, p = .812, ηp2 = .002. 
Social behaviors during social interactions. For the UCT, there were no significant 
differences between treatment conditions on the percent of time making eye/facial gaze during 
the task, F(1,28) = 3.452, p = .074, ηp2 = .110. The two conditions did differ significantly on the 
duration of time speaking during the task. Participants in the AT condition spoke significantly 
longer (55.25% of time in the task) than those in the AC condition (51.90%; d = .20), F(1,28) = 
4.454, p = .044, ηp2 = .137. 
For the IST,  participants in the two treatment conditions did not differ significantly at 
post-treatment on the percent of time making eye/facial gaze during the task, F(1,28) = 1.348, p 
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= .255, ηp
2 = .046. The two conditions did differ significantly on the duration of time speaking 
during the task. Participants in the AC condition spoke significantly longer (89.33% of the time 
in the task) than those in the AT condition (84.82%, d = .28), F(1,28) = 4.395, p = .045, ηp2 
= .136. Some participants did not speak at all but stood silently before ending the task. Escape 
was defined as the number of participants who requested to end the IST early due to 
overwhelming anxiety. Results of the chi square test revealed no group difference in the number 
of participants who escaped the IST (86.7% versus 100% for the AT and AC conditions, 
respectively; χ2[1, 31] = 2.280, p = .131, Φ = .271). The groups also did not differ significantly 
on the length of time they remained in the task prior to escape, F(1,28) = 1.012, p = .323, ηp2 
= .035. 
Treatment Credibility 
 Participants in the two treatment conditions did not differ significantly on how confident 
they were in treatment, F(1,27) = .063, p = .804, ηp2 = .002, how logical the treatment seemed to 
them, F(1,27) = .127, p = .847, ηp2 = .064, or how confident they would be in recommending the 
treatment to a friend, F(1,27) = .441, p = .512, ηp2 = .016. 
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Table 2 
Means and standard deviations of study outcome variables at pre- and post-treatment 
  Pre  Post   
  AT AC  AT AC   
  M (SD) M (SD)  M (SD) M (SD)  d 
Severity         
     CGI-S  5.20 (.86) 5.19 (.75)  4.67 (.90) 4.81 (.54)  .19 
     CGI-I  - -  3.67 (.72) 3.75 (.44)  .13 
     BARS  4.27 (.80) 4.13 (.80)  3.87 (.99) 3.88 (.95)  .01 
Social Anxiety         
     BSPS  48.73 (8.59) 48.43 (8.51)  43.66 (9.31) 42.93 (11.18)  .07 
     SPAI  106.80 (15.48) 111.24 (23.75)  86.36 (28.88) 95.81 (19.38)  .38 
     LSAS-SR  86.66 (18.25) 76.80 (22.21)  59.93 (20.01) 66.37 (22.67)  .30 
Depression         
     BDI-II  16.00 (10.88) 15.31 (11.06)  11.93 (10.84) 14.06 (11.33)  .19 
Behavioral Assessment         
  UCT          
     Anxiety  5.40 (1.59) 5.43 (2.06)  3.20 (2.24) 3.56 (1.36)  .19 
     Eye-gaze (%)  45.22 (18.21) 49.27 (17.83)  52.32 (19.10) 57.61 (22.03)  .25 
     Speaking (%)  38.93 (17.01) 45.15 (14.33)  55.25 (16.15) 51.90 (16.94)  .20 
  IST         
     Anxiety  6.73 (2.01) 6.56 (1.75)  5.20 (2.21) 4.93 (1.95)  .13 
     Eye-gaze (%)  36.37 (24.83) 40.28 (22.96)  32.60 (20.28) 42.96 (29.74)  .40 
     Speaking (%)  80.51 (19.73) 73.05 (22.64)  84.82 (16.54) 89.33 (14.97)  .28 
     Before escape(s)  272.01 (161.92) 236.62 (109.92)  346.47 (167.55) 278.73 (132.10)  .45 
Credibility         
     Confidence  - -  .85 (.66) .80 (.56)  .08 
     Logicalness  - -  .71 (.72) .40 (.50)  .50 
     Recommend  - -  .93 (.61) .80 (.41)  .25 
Note. CGI-S = Clinical Global Impressions-Severity (Guy, 1976); CGI-I = Clinical Global 
Impressions-Improvement (Guy, 1976); BARS Behavioral Avoidance Rating Scale (Beidel et al., 
2007); BSPS = Brief Social Phobia Scale (Davidson et al., 1991); SPAI = Social Phobia and 
Anxiety Inventory (Turner et al., 1989; Turner, Beidel, & Dancu, 1996); LSAS-SR = Liebowitz 
Social Anxiety Scale-Self Report (Liebowitz, 1987); BDI-II = Beck Depression Inventory–II 
(Beck, Steer, & Brown, 1996); UCT = Unstructured Conversation Task (Turner, Beidel, Cooley, 
Woody, & Messer, 1994); IST = Impromptu Speech Task (Beidel et al., 2010). d = Cohen’s d. d 
was calculated as between group effect size at post-treatment and does not account for variation 
in pre-treatment scores. 
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DISCUSSION 
This was the first study to explicitly replicate previous methodology for attention training 
for social anxiety (Amir et al., 2009; Schmidt et al., 2009) but also expand the assessment of 
patient outcome to include behavioral assessment. The results of this investigation revealed that 
all participants met DSM-IV-TR criteria for SAD at post-treatment despite treatment condition. 
Consistently, scores on the SPAI did not differ between the two conditions at post-treatment, 
even when accounting for pre-treatment differences. Finally, between-group differences on self-
reported anxiety and blinded observer ratings of social behavior during in-vivo social 
interactions (i.e., the UCT and IST) were not observed. No differences were found for social skill 
variables such as eye/facial gaze, time before escape, or the number of participants who escaped 
during the IST. Only two behavioral indices indicated group differences, although the results did 
not favor one group over the other. 
With regard to diagnosis at post-treatment, it was expected that some participants in the 
AT condition would no longer meet criteria for SAD given rates of recovery reported in prior 
investigations (i.e., Amir et al., 2009; Schmidt et al., 2009) yet this was not the case in this 
investigation. Although we used a different diagnostic interview, diagnoses were reliable and 
accurate, as reflected by high inter-rater reliability. During post-treatment diagnostic interviews, 
all participants reported experiencing considerable distress and avoidance in social situations, 
few reported noticing positive change in their condition, and all participants requested additional 
treatment. Furthermore, data from clinician- and self-report measures revealed no group 
differences on any measures (i.e., the BSPS, SPAI, and LSAS-SR). Average scores on self-report 
measures at post-treatment fell at or above the recommended cutoff criteria for probable SAD 
(approximately 60 for the LSAS-SR [Rytwinski et al., 2009] and the SPAI [Turner, Beidel & 
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Dancu, 1996]). Post-treatment between-group differences on these measures were smaller than 
those observed in the Amir et al. (2009) investigation, as reflected by between-group effect sizes 
at post-treatment (d = .30 to .38). 
A close perusal of Table 2 reveals decreases on all measures for both treatment 
conditions. This is to be expected, though, considering non-specific treatment effects that might 
occur simply from attending therapy (e.g., the development of patient-therapist relationships; see 
Patterson [1985] for a review of therapist-related variables associated with non-specific 
treatment effects) and underscores the need for placebo control conditions in randomized 
controlled trials. In some instances, decreases in symptomology may shift a patient’s status to the 
extent that he/she no longer experiences functional impairment even if occasional fears/worries 
remain. However, in this investigation decreases in symptom severity did not result in a loss of 
diagnosis for any patients, suggesting all participants were still functionally impaired. 
The addition of a behavioral assessment of social anxiety and social behavior is unique to 
this investigation and provides an important clinical perspective on patient functioning. In 
particular, rather than examining solely statistically significant changes on self-report measures 
of patient functioning, clinically significant change in real-world functioning may be more 
closely examined (Kazdin, 1999). Significant differences between groups on speech duration 
during the two tasks were found at post-treatment, although these differences did not favor one 
group over the other (i.e., the AT group spoke longer during the UCT and the AC group spoke 
longer during the IST; see Figure 2). However, between group effect sizes at post-treatment were 
small (i.e., d = .20 to .28), suggesting that any gains were minimal. 
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Figure 2 
Percent of time speaking during the post-treatment behavioral assessment 
 
Another unique aspect of this investigation is the assessment of participants’ perception 
of treatment credibility. In addition to the lack of group difference, both groups endorsed low 
ratings with regard to their confidence in the treatment, the logicalness of the treatment, and the 
likelihood that they would recommend the treatment to a friend. This low confidence, of course, 
could be related to the lack of treatment outcome, although the similarly low levels of confidence 
reported by both groups suggests that confidence did not relate to the lack of differential 
between-group effects for the treatment. 
Implications 
 The results of the current investigation do not support the efficacy of attention training 
for the treatment of SAD and are consistent with other recent investigations finding negative 
effects for modified versions of this treatment (Boettcher et al., 2011; Carlbring et al., 2012; 
Heeren et al., 2012; Neubauer et al., 2012). Consistent with Emmelkamp (2012)’s statement that 
“there is no robust evidence that attention training is of clinical value,” the results of this study 
provide further support for this claim. Why the positive response of the initial investigations has 
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not withstood the test of replication is unclear but merits further research. Given the significant 
prevalence of this disorder, establishing the efficacy of a range of interventions remains an 
important goal of clinical research. Furthermore, efficacious interventions that may be 
administered by sub-doctoral level clinicians are necessary. At this time, there are questions 
regarding the ability of attentional training therapies to deliver their initial promise. 
Limitations 
 There are several limitations of this investigation. First, the limited sample size raises 
concerns regarding the adequacy of power to detect significant differences across groups. 
However, an a priori power analysis using power of .80 and a medium effect size indicated that 
the current sample would be acceptable for the planned analyses. Furthermore the current study’s 
sample size (n = 31) exceeded that of others (e.g., Schmidt et al., 2009) at follow-up (n = 26), the 
only time-point at which significant differences between groups were observed. Second, the 
demographics of the current sample appear to differ somewhat from those of Amir et al. (2009). 
Particularly, the average age of the current sample was somewhat younger and slightly more 
diverse with respect to race/ethnicity. It is possible that these differences may have affected the 
credibility of computer-based intervention modalities and hence their effectiveness, although the 
interplay of these factors has yet to be studied for this intervention. Third, the generalizability of 
this study’s behavioral assessment as an analogue for day-to-day social interactions may appear 
limited. However, decades of research affirm the ability of these tasks to approximate in-vivo 
interactions and in this study the tasks elicited a significant level of anxiety in the participants. 
Clearly, behavioral assessment is an important tool in understanding functional impairment 
relative to various psychopathologies, particularly SAD. 
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Conclusion 
 This study was an attempt to replicate previous investigations of attention training  as a 
treatment for adult SAD (i.e., Amir et al., 2009; Schmidt et al., 2009) using a multimodal 
assessment of patient functioning. Consistent with other studies investigating modified versions 
of this protocol, we were unable to replicate the positive results of these initial investigations 
based on either patient- or clinician-report, as well as behavioral assessment of social functioning. 
Future investigations should seek to further elucidate the exact mechanisms by which these 
treatments may affect levels of social anxiety in patients with SAD. 
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